Target intelligence / Profile preview

Integrin alpha-V beta-3, alpha-V beta-5, alpha-5 beta-1, and alpha-M beta-2 receptors (αVβ3, αVβ5, α5β1, αMβ2)

Target
αVβ3, αVβ5, α5β1, αMβ2
Molecular classification
Receptor, Integrin family, Cell adhesion receptor
01

Overview

Integrins are a superfamily of cell adhesion heterodimeric transmembrane receptors, each consisting of specific alpha and beta subunits, that mediate cell–cell and cell–extracellular matrix interactions. While presented together in this summary, Integrin alpha-V beta-3, alpha-V beta-5, alpha-5 beta-1, and alpha-M beta-2 receptors are distinct molecular entities with unique binding specificities and tissue distributions. Integrin alpha-V beta-3 and alpha-V beta-5 are RGD-binding receptors recognized for their roles in angiogenesis, tumor invasion, and regulation of cell migration through binding to vitronectin, fibronectin, osteopontin, and other ECM proteins. Integrin alpha-5 beta-1 is the main fibronectin receptor, playing a central role in development, cell adhesion, migration, and ECM structure. Integrin alpha-M beta-2 (Mac-1, CR3) is primarily expressed on myeloid and certain immune cells, mediating leukocyte adhesion, migration, and phagocytosis in inflammation and immune responses. Each integrin plays distinct and overlapping biological roles, and several are actively pursued as drug targets in oncology, fibrosis, and immune-related diseases, although clinical translation has been challenging due to on-target adverse effects and context-specific biology.

Other names
vitronectin receptorfibronectin receptorMac-1CR3 (complement receptor 3)
02

Mechanism of action

Competitive inhibition of ligand (RGD motif-containing proteins like fibronectin or vitronectin) binding Antagonism of integrin-mediated cell adhesion, migration, and survival Modulation or inhibition of downstream signaling pathways involved in proliferation, migration, and immune activation

03

Biological functions

Cell adhesionSignal transductionCell migrationAngiogenesis (esp. αVβ3, αVβ5)Immune response and phagocytosis (esp. αMβ2)Cell differentiationECM (extracellular matrix) remodeling and regulation
04

Disease associations

Cancer (angiogenesis, invasion, metastasis)FibrosisInflammationCardiovascular disease (atherosclerosis, thrombosis)Osteoporosis (bone resorption)Autoimmune diseasesInfection and immune disorders (esp. αMβ2)
05

Safety considerations

On-target effects on normal tissue healing, hemostasis, or immune surveillanceBleeding or thrombosis risk (notable for αV class and related integrins)Immunosuppression and increased infection risk (notable for immune-cell integrins like αMβ2)Potential for paradoxical effects (e.g., tumor progression)
06

Interacting drugs

Cilengitide (αVβ3, αVβ5 inhibitor)

4 more in the full profile.

07

Biomarkers

High surface expression of specific integrin heterodimers on tumor, stromal, endothelial, or immune cells (context-dependent)Elevated levels of integrin ligands (e.g., fibronectin, vitronectin) in tissue microenvironmentImaging agents targeting integrins for PET/SPECT imaging in cancer and fibrosis

Beyond the preview

Go deeper on Integrin alpha-V beta-3, alpha-V beta-5, alpha-5 beta-1, and alpha-M beta-2 receptors (αVβ3, αVβ5, α5β1, αMβ2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Integrin alpha-V beta-3, alpha-V beta-5, alpha-5 beta-1, and alpha-M beta-2 receptors (αVβ3, αVβ5, α5β1, αMβ2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call